Fusion peptides with binding activity for streptavidin
AssigneeInstitut Fur Bioanalytik Gemeinnutzige Gesellschaft MBH
InventorsArne Skerra, Thomas Schmidt
Life of this patent
Estimating the term…
Loading patent…
AssigneeInstitut Fur Bioanalytik Gemeinnutzige Gesellschaft MBH
InventorsArne Skerra, Thomas Schmidt
Estimating the term…
A peptide according to the invention comprises the amino acid sequence Trp--X--His--Pro--Gln--Phe--Y--Z, in which X represents any desired amino acid and Y and Z either both denote Gly, or Y denotes Glu and Z denotes Arg or Lys. A fusion protein according to the invention consists of the amino acid sequence of a complete protein, of a protein mutant such as a deletion mutant or substitution mutant, or of part of a protein linked to the sequence of a peptide of the invention. For the production of a recombinant protein by expression of a DNA sequence coding therefor in suitable host cells according to well-known methods, a DNA sequence is used which codes for a fusion protein and, if desired, the presence of the expression product is detected by means of a conjugate of streptavidin and a label or the desired protein is separated as a fusion protein by means of streptavidin affinity chromatography.
An isolated peptide comprising the amino acid sequence Trp--X--His --Pro--Gln--Phe--Y--Z, wherein X represents any amino acid residue, and Y and Z both represent Gly or where Y represents Glu, Z represents Arg or Lys.
Dependencies are inferred from the claim text.